Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)

ClinicalTrials.gov ID: NCT02943577

Public ClinicalTrials.gov record NCT02943577. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 8:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the efficacy, safety, and tolerability of rapastinel 450 milligrams (mg) compared to placebo adjunctive to antidepressant therapy (ADT) in patients with major depressive disorder (MDD) who have a partial response to ADT.

Study identification

NCT ID
NCT02943577
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
429 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2, 2016 (Actual)
Primary completion
Oct 26, 2018 (Actual)
Completion
Nov 21, 2018 (Actual)
Last update posted
Nov 13, 2019

2016 – 2018

United States locations

U.S. sites
40
U.S. states
23
U.S. cities
37
Facility City State ZIP Site status
Harmonex Neuroscience Research Dothan Alabama 36303 —
NoesisPharma Phoenix Arizona 85016 —
Sun Valley Research Center Imperial California 92251 —
Irvine Center for Clinical Research, Inc Irvine California 92614 —
NRC Research Institute Orange California 92868 —
Asclepes Research Centers Panorama City California 91402 —
Artemis Institute for Clinical Research San Marcos California 92078 —
MCB Clinical Research Center Colorado Springs Colorado 80910 —
Gulfcoast Clinical Research Center Fort Myers Florida 33912 —
Research Centers of America Hollywood Florida 33024 —
Innova Clinical Trials Inc. Miami Florida 33133 —
Combined Research Orlando Phase I-IV Orlando Florida 32807 —
Olympian Clinical Research Tampa Florida 33609 —
The University of South Florida Board of Trustees, A public Body Corporate, for University of South Florida Tampa Florida 33613 —
Northwest Behavioral Research Center Marietta Georgia 30060 —
AMR - Baber Research, Inc. Naperville Illinois 60563 —
Psychiatric Associates Overland Park Kansas 66211 —
Louisiana Clinical Research Shreveport Louisiana 71101 —
Sheppard Pratt Health System Baltimore Maryland 21204 —
University of Massachusetts Medical School Worcester Massachusetts 01655 —
Psychiatric Care and Research Center O'Fallon Missouri 63368 —
St. Charles Psychiatric Associates - Midwest Research Group Saint Charles Missouri 63304 —
Alivation Research Lincoln Nebraska 68526 —
Healthy Perspectives - Innovative Mental Health Services. PLLC Nashua New Hampshire 03060 —
Hassman Research Institute, LLC Berlin New Jersey 08009 —
Global Medical Institute, LLC Princeton New Jersey 08540 —
Bio Behavioral Health Toms River New Jersey 08755 —
Albuquerque Neuroscience, Inc Albuquerque New Mexico 87109 —
SPRI Clinical Trials, Inc Brooklyn New York 11235 —
Manhattan Behavioral Medicine New York New York 10036 —
Fieve Clinical Research New York New York 10168 —
New Hope Clinical Research Inc. Charlotte North Carolina 28211 —
Dr. Cherian Verghese Norristown Pennsylvania 20006 —
Research Strategies of Memphis, LLC Memphis Tennessee 38119 —
Houston Clinical Trials, LLC Bellaire Texas 77401 —
North Texas Clinical Trials Fort Worth Texas 76104 —
Grayline Clinical Drug Trials Wichita Falls Texas 76309 —
Psychiatric and Behavioral Solutions Salt Lake City Utah 84105 —
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia Charlottesville Virginia 22903 —
Psychiatric Alliance of the Blue Ridge, Inc. Charlottesville Virginia 22903 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02943577, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 13, 2019 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02943577 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →